Ureter Cancer Pipeline Repoty H1 2016 - Review of Altor BioScience, Eisai, Exelixis & Merck & Their Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Ureter Cancer - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Ureter Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ureter Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Ureter Cancer Overview
  3. Therapeutics Development
  4. Pipeline Products for Ureter Cancer - Overview
  5. Pipeline Products for Ureter Cancer - Comparative Analysis
  6. Ureter Cancer - Therapeutics under Development by Companies
  7. Ureter Cancer - Therapeutics under Investigation by Universities/Institutes
  8. Ureter Cancer Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Ureter Cancer - Products under Development by Companies
  13. Ureter Cancer - Products under Investigation by Universities/Institutes
  14. Ureter Cancer - Companies Involved in Therapeutics Development
  • Altor BioScience Corporation
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • Merck & Co., Inc.

For more information visit http://www.researchandmarkets.com/research/xpm2ql/ureter_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Kidney Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Kidney Cancer Drugs